MedTrace Logo

Effects of Antiemetic Agents in Orthognathic Surgery Patients

NCT06454825 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2024-06-12

No results posted yet for this study

Summary

In an effort to prevent or treat consistently high rates of PONV following maxillofacial operations, several medications, techniques and multimodal protocols have been studied. In the present study, the investigators hypothesized that combining metoclopramide with granisetron will improve PONV incidence when compared with granisetrone alone.

Conditions

  • Emesis, Postoperative
  • Maxillofacial Abnormalities

Interventions

DRUG

Intravenous drug

medications were applied intravenously to the groups 30 minutes before end of the procedure

Sponsors & Collaborators

  • Bezmialem Vakif University

    lead OTHER

Principal Investigators

  • ÖZGE 3 ÖZYILMAZ, DDS · Bezmialem Vakif University, Faculty of Dentistry

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-14
Primary Completion
2021-04-05
Completion
2021-04-05

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06454825 on ClinicalTrials.gov